Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients

Galohgor nutraceutical (GN) is a polyherbal product from the Sundanese ethnic group in Indonesia. GN contains antioxidants and other bioactive compounds that have shown synergistic effects in controlling blood glucose in animal models and significantly decreasing oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM). The aim of this study was to analyze the effect of GN on the fasting blood glucose (FBG) levels of T2DM subjects. A quasi-experimental pre-post-controlled trial design was conducted with 26 subjects divided into two groups: intervention and control. One subject from the control group and 6 from the GN group were excluded due to illness or voluntary withdrawal. The study was conducted in the Bogor District, West Java, over a 38-day intervention period. The formulation of the GN cookies and powdered drinks in the intervention group was similar to the control group, but supplemented with 2 g of GN powder daily, which was added in 24 g of cookies (containing 1 g of GN/serving size) and one pack of powdered drinks (containing 1 g of GN/serving size). The study received ethical approval (No.422/III/LPPM-PM.10.05/05/2016). Physical activity was measured using the International Physical Activity Questionnaire (IPAQ). Food intake data were obtained via a 24-h food record and recall combination at the beginning and during the intervention. The frequency of high glycemic index (GI) carbohydrate consumption was measured using a semi-quantitative food frequency questionnaire (SQ-FFQ). Differences in FBG between groups were tested using ANCOVA. At baseline, the FBG levels of the GN intervention and control groups were 267.5 mg/dL and 241.5 mg/dL, respectively. FBG significantly decreased in the GN intervention group compared to the control group (p<0.015). This study was limited by its quasi-experimental pre-post design and small sample size which may have introduced selection bias and limited generalizability. To elaborate on the potential effects and mechanisms of GN as an antidiabetic agent, further studies should be conducted with larger, randomized T2DM cohorts using standardized GN products.

Authors

Institutions

Publication Details

Journal
Journal of Food Health and Bioenvironmental Science
Published
2026-11-13
DOI
https://doi.org/10.65763/jfhb.2026.e269842
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients

Rosyanne Kushargina, Rimbawan Rimbawan, Ratih Putri Damayati, Makiko Sekiyama et al.
1 links
Journal of Food Health and Bioenvironmental Science
Natural Antidiabetic Agents Studies
article

Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients

Rosyanne Kushargina, Rimbawan Rimbawan, Ratih Putri Damayati, Makiko Sekiyama, Katrin Roosita
article en

Abstract

Galohgor nutraceutical (GN) is a polyherbal product from the Sundanese ethnic group in Indonesia. GN contains antioxidants and other bioactive compounds that have shown synergistic effects in controlling blood glucose in animal models and significantly decreasing oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM). The aim of this study was to analyze the effect of GN on the fasting blood glucose (FBG) levels of T2DM subjects. A quasi-experimental pre-post-controlled trial design was conducted with 26 subjects divided into two groups: intervention and control. One subject from the control group and 6 from the GN group were excluded due to illness or voluntary withdrawal. The study was conducted in the Bogor District, West Java, over a 38-day intervention period. The formulation of the GN cookies and powdered drinks in the intervention group was similar to the control group, but supplemented with 2 g of GN powder daily, which was added in 24 g of cookies (containing 1 g of GN/serving size) and one pack of powdered drinks (containing 1 g of GN/serving size). The study received ethical approval (No.422/III/LPPM-PM.10.05/05/2016). Physical activity was measured using the International Physical Activity Questionnaire (IPAQ). Food intake data were obtained via a 24-h food record and recall combination at the beginning and during the intervention. The frequency of high glycemic index (GI) carbohydrate consumption was measured using a semi-quantitative food frequency questionnaire (SQ-FFQ). Differences in FBG between groups were tested using ANCOVA. At baseline, the FBG levels of the GN intervention and control groups were 267.5 mg/dL and 241.5 mg/dL, respectively. FBG significantly decreased in the GN intervention group compared to the control group (p<0.015). This study was limited by its quasi-experimental pre-post design and small sample size which may have introduced selection bias and limited generalizability. To elaborate on the potential effects and mechanisms of GN as an antidiabetic agent, further studies should be conducted with larger, randomized T2DM cohorts using standardized GN products.

Journal of Food Health and Bioenvironmental ScienceVol. 19(3)
National Institute for Environmental Studies (JP), IPB University (ID), Universitas Muhammadiyah Jakarta (ID), Politeknik Negeri Jember (ID)
Good health and well-being
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon